136 related articles for article (PubMed ID: 6366708)
1. Destruction of elastic tissue (elastolysis) as a link between atherosclerosis and the temporal arteritis/polymyalgia rheumatica syndrome. Observations on an actinic factor in vascular disease.
O'Brien JP
Pathol Biol (Paris); 1984 Feb; 32(2):123-38. PubMed ID: 6366708
[TBL] [Abstract][Full Text] [Related]
2. The role of actinically provoked systemic elastolysis in polymyalgic vascular disease. A study based on serum fluorescence and haptoglobin.
O'Brien JP; Argyle JC
Am J Dermatopathol; 1981; 3(3):273-86. PubMed ID: 7325340
[TBL] [Abstract][Full Text] [Related]
3. A study of elastic tissue and actinic radiation in "aging," temporal arteritis, polymyalgia rheumatica, and atherosclerosis. The actinic storm in the modern world.
O'Brien JP; Regan W
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):765-76. PubMed ID: 1869651
[TBL] [Abstract][Full Text] [Related]
4. A concept of diffuse actinic arteritis. The role of actinic damage to elastin in 'age change' and arteritis of the temporal artery and in polymyalgia rheumatica.
O'Brien JP
Br J Dermatol; 1978 Jan; 98(1):1-13. PubMed ID: 626708
[TBL] [Abstract][Full Text] [Related]
5. Giant cell arteritis-a systemic spectrum including temporal arteritis and polymyalgia rheumatica.
Atkins SD
J Fam Pract; 1978 Dec; 7(6):1109-11. PubMed ID: 748486
[TBL] [Abstract][Full Text] [Related]
6. Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis.
Nordborg C; Larsson K; Aman P; Nordborg E
Scand J Rheumatol; 2009; 38(2):144-8. PubMed ID: 19177264
[TBL] [Abstract][Full Text] [Related]
7. [Calcifications in temporal arteries -- their morphogenesis in comparison to physiological osteogenesis].
Mohr W; Görz E
Z Kardiol; 2003 Jan; 92(1):60-72. PubMed ID: 12545303
[TBL] [Abstract][Full Text] [Related]
8. Vascular accidents after actinic (solar) exposure. An aspect of the temporal arteritis/polymyalgia rheumatica syndrome.
O'Brien JP
Int J Dermatol; 1987; 26(6):366-70. PubMed ID: 3623793
[TBL] [Abstract][Full Text] [Related]
9. Temporal arteritis in polymyalgia rheumatica: immune complex deposits and the role of the leukocyte elastase in the pathogenesis.
Velvart M; Felder M; Fehr K; Sommermeyer G; Cancer M; Wagenhäuser FJ; Böni A
Z Rheumatol; 1983; 42(6):320-7. PubMed ID: 6559532
[TBL] [Abstract][Full Text] [Related]
10. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
Ann Intern Med; 1994 Oct; 121(7):484-91. PubMed ID: 8067646
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?
Espinosa G; Font J; Muñoz-Rodríguez FJ; Cervera R; Ingelmo M
Clin Rheumatol; 2002 Aug; 21(4):309-13. PubMed ID: 12189460
[TBL] [Abstract][Full Text] [Related]
13. [Hutchinson-Horton giant cell arteritis and rhizomelic polymyalgia. III. Current pathogenetic and nosographic aspects].
Lovisetto P; Marchi L; Gilardi E; Mairano D; Biarese V
Minerva Med; 1984 May; 75(19):1103-10. PubMed ID: 6728260
[TBL] [Abstract][Full Text] [Related]
14. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia rheumatica-temporal arteritis syndrome.
Lesser RS; Aledort D; Lie JT
J Rheumatol; 1995 Nov; 22(11):2177-82. PubMed ID: 8596167
[TBL] [Abstract][Full Text] [Related]
15. [Polymyalgia rheumatica and giant cell arteritis, clinical and histopathological study of three cases].
Di Giacomo V; Meloni F; Carmenini G; Cavallaro A; Sciacca V
G Ital Cardiol; 1983; 13(5):380-4. PubMed ID: 6618059
[TBL] [Abstract][Full Text] [Related]
16. Elastase derived elastin peptides: putative autoimmune targets in giant cell arteritis.
Gillot JM; Masy E; Davril M; Hachulla E; Hatron PY; Devulder B; Dessaint JP
J Rheumatol; 1997 Apr; 24(4):677-82. PubMed ID: 9101501
[TBL] [Abstract][Full Text] [Related]
17. A controlled hematoxylin-eosin for actinic elastosis-lysis. Its versatility and use for vascular damage (actinic arteriopathy) in the skin and orbit.
O'Brien JP
Am J Dermatopathol; 1994 Feb; 16(1):31-50; discussion 36. PubMed ID: 7512799
[TBL] [Abstract][Full Text] [Related]
18. Actinically degenerate elastic tissue: the prime antigen in the giant cell (temporal) arteritis syndrome? New data from the posterior ciliary arteries.
O'Brien JP; Regan W
Clin Exp Rheumatol; 1998; 16(1):39-48. PubMed ID: 9543560
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis.
Uddhammar AC
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S32-3. PubMed ID: 10948757
[TBL] [Abstract][Full Text] [Related]
20. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
